Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cough/Cold, Analgesic Patch Sales Ease Pain Of Private Label Growth In OTCs

Executive Summary

Topical analgesic sales grew double digits in 2017 on innovation and adhesive patch launches, helping drive 2.1% growth of US manufacturers' OTC drug sales in 2017 to $21.2bn, Kline & Co. independent consultant Laura Mahecha says. But private label continues to outpace branded product sales growth.

Advertisement

Related Content

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance
Some Health And Wellness Categories Find Sales Niche In Independent Pharmacies
GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi
OTC Switch Interest Cooled By Study Costs To Update Safety Data
Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval
Industry Roundup: P&G Leadership, Unilever Sale, Ad Claims

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124017

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel